| Heading: |
Motor Neurone Disease: Health Services |
| Question ID: |
1809308 |
| UIN: |
57324 |
| House: |
Commons |
| Date tabled: |
2025-06-04 |
| Asking Member ID: |
4673 |
| Asking Member display name: |
Jo Platt
|
| Asking Member handle: |
JoPlattLeigh
|
| Asking Member Twitter reference: |
@JoPlattLeigh
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, to make an assessment of the capacity to deliver Early Access Programmes for people with motor neurone disease. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-06-10 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
Companies may put in place Early Access Programmes (EAPs) to allow early access to new medicines that do not yet have a marketing authorisation. Participation in EAPs is decided at an individual National Health Service trust level and under these programm... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |